$NVIV Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INVIVO THERAPEUTICS HOLDINGS CORP..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in INVIVO THERAPEUTICS HOLDINGS CORP.. Get notifications about new insider transactions in INVIVO THERAPEUTICS HOLDINGS CORP. for free.

Page: < prev 1 2 3 4 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 09 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.52	12,000	54,240	12,711,020	12.7 M to 12.7 M (-0.09 %)
Aug 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.53	12,000	54,360	12,723,020	12.7 M to 12.7 M (-0.09 %)
Aug 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.18	12,000	50,160	12,735,020	12.7 M to 12.7 M (-0.09 %)
Aug 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.66	12,000	55,920	12,747,020	12.8 M to 12.7 M (-0.09 %)
Aug 02 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.48	12,000	53,760	12,759,020	12.8 M to 12.8 M (-0.09 %)
Aug 02 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.66	12,000	55,920	12,771,020	12.8 M to 12.8 M (-0.09 %)
Jul 31 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.12	12,000	61,440	12,783,020	12.8 M to 12.8 M (-0.09 %)
Jul 31 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.09	12,000	61,080	12,795,020	12.8 M to 12.8 M (-0.09 %)
Jul 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.14	12,000	61,680	12,807,020	12.8 M to 12.8 M (-0.09 %)
Jul 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.43	12,000	65,160	12,819,020	12.8 M to 12.8 M (-0.09 %)
Jul 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.66	12,000	67,920	12,831,020	12.8 M to 12.8 M (-0.09 %)
Jul 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.68	12,000	68,160	12,843,020	12.9 M to 12.8 M (-0.09 %)
Jul 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.83	12,000	69,960	12,855,020	12.9 M to 12.9 M (-0.09 %)
Jul 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.36	12,000	64,320	12,867,020	12.9 M to 12.9 M (-0.09 %)
Jul 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.18	12,000	62,160	12,879,020	12.9 M to 12.9 M (-0.09 %)
Jul 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.28	12,000	63,360	12,891,020	12.9 M to 12.9 M (-0.09 %)
Jul 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	5.12	12,000	61,440	12,903,020	12.9 M to 12.9 M (-0.09 %)
Jul 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.95	12,000	59,400	12,915,020	12.9 M to 12.9 M (-0.09 %)
Jul 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.57	12,000	54,840	12,927,020	12.9 M to 12.9 M (-0.09 %)
Jul 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.28	12,000	51,360	12,939,020	13 M to 12.9 M (-0.09 %)
Jul 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.97	12,000	47,640	12,951,020	13 M to 13 M (-0.09 %)
Jul 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.94	12,000	47,280	12,963,020	13 M to 13 M (-0.09 %)
Jul 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.01	12,000	48,120	12,975,020	13 M to 13 M (-0.09 %)
Jul 05 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.00	12,000	48,000	12,987,020	13 M to 13 M (-0.09 %)
Jul 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.01	12,000	48,120	12,999,020	13 M to 13 M (-0.09 %)
Jul 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.10	12,000	49,200	13,011,020	13 M to 13 M (-0.09 %)
Jul 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.14	12,000	49,680	13,023,020	13 M to 13 M (-0.09 %)
Jun 28 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.16	12,000	49,920	13,035,020	13 M to 13 M (-0.09 %)
Jun 28 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.27	12,000	51,240	13,047,020	13.1 M to 13 M (-0.09 %)
Jun 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.10	12,000	49,200	13,059,020	13.1 M to 13.1 M (-0.09 %)
Jun 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.79	12,000	45,480	13,071,020	13.1 M to 13.1 M (-0.09 %)
Jun 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.73	12,000	44,760	13,083,020	13.1 M to 13.1 M (-0.09 %)
Jun 21 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.76	12,000	45,120	13,095,020	13.1 M to 13.1 M (-0.09 %)
Jun 21 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.80	12,000	45,600	13,107,020	13.1 M to 13.1 M (-0.09 %)
Jun 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.79	12,000	45,480	13,119,020	13.1 M to 13.1 M (-0.09 %)
Jun 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.82	12,000	45,840	13,131,020	13.1 M to 13.1 M (-0.09 %)
Jun 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.07	12,000	48,840	13,143,020	13.2 M to 13.1 M (-0.09 %)
Jun 14 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.88	12,000	46,560	13,155,020	13.2 M to 13.2 M (-0.09 %)
Jun 14 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.79	12,000	45,480	13,167,020	13.2 M to 13.2 M (-0.09 %)
Jun 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.14	4,250	17,595	13,179,020	13.2 M to 13.2 M (-0.03 %)
Jun 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.36	4,250	18,530	13,183,270	13.2 M to 13.2 M (-0.03 %)
Jun 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.51	4,250	19,168	13,187,520	13.2 M to 13.2 M (-0.03 %)
Jun 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	4.12	4,250	17,510	13,191,770	13.2 M to 13.2 M (-0.03 %)
Jun 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.91	4,250	16,618	13,196,020	13.2 M to 13.2 M (-0.03 %)
Jun 05 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.91	2,500	9,775	7,433,628	7.4 M to 7.4 M (-0.03 %)
Jun 05 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.90	2,500	9,754	7,436,128	7.4 M to 7.4 M (-0.03 %)
Jun 05 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.37	2,500	8,432	7,436,378	7.4 M to 7.4 M (-0.03 %)
Jun 05 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.89	4,250	16,533	13,200,270	13.2 M to 13.2 M (-0.03 %)
Jun 05 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.85	4,250	16,363	13,204,520	13.2 M to 13.2 M (-0.03 %)
Jun 05 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.51	4,250	14,918	13,208,770	13.2 M to 13.2 M (-0.03 %)
May 31 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.39	2,500	8,475	7,438,878	7.4 M to 7.4 M (-0.03 %)
May 31 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.40	2,500	8,500	7,441,378	7.4 M to 7.4 M (-0.03 %)
May 31 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.13	2,500	7,825	7,443,878	7.4 M to 7.4 M (-0.03 %)
May 31 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.30	4,250	14,025	13,213,020	13.2 M to 13.2 M (-0.03 %)
May 31 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.33	4,250	14,153	13,217,270	13.2 M to 13.2 M (-0.03 %)
May 29 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.14	4,250	13,345	13,221,520	13.2 M to 13.2 M (-0.03 %)
May 29 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.11	4,250	13,218	13,225,770	13.2 M to 13.2 M (-0.03 %)
May 28 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.03	2,500	7,570	7,446,378	7.4 M to 7.4 M (-0.03 %)
May 28 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.97	2,500	7,420	7,448,878	7.5 M to 7.4 M (-0.03 %)
May 28 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.90	2,500	7,250	7,451,378	7.5 M to 7.5 M (-0.03 %)
May 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.00	4,250	12,750	13,230,020	13.2 M to 13.2 M (-0.03 %)
May 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.89	4,250	12,283	13,234,270	13.2 M to 13.2 M (-0.03 %)
May 22 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.89	2,500	7,220	7,453,878	7.5 M to 7.5 M (-0.03 %)
May 22 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.87	2,500	7,180	7,456,378	7.5 M to 7.5 M (-0.03 %)
May 22 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.88	2,500	7,210	7,458,878	7.5 M to 7.5 M (-0.03 %)
May 17 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.86	2,500	7,157	7,461,378	7.5 M to 7.5 M (-0.03 %)
May 17 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.84	2,500	7,090	7,463,878	7.5 M to 7.5 M (-0.03 %)
May 17 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.85	2,500	7,115	7,466,378	7.5 M to 7.5 M (-0.03 %)
May 22 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.88	4,250	12,240	13,238,520	13.2 M to 13.2 M (-0.03 %)
May 22 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.87	4,250	12,198	13,242,770	13.2 M to 13.2 M (-0.03 %)
May 22 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.88	4,250	12,240	13,247,020	13.3 M to 13.2 M (-0.03 %)
May 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.87	4,250	12,198	13,251,270	13.3 M to 13.3 M (-0.03 %)
May 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.86	4,250	12,155	13,255,520	13.3 M to 13.3 M (-0.03 %)
May 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.84	4,250	12,070	13,259,770	13.3 M to 13.3 M (-0.03 %)
May 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.88	4,250	12,240	13,264,020	13.3 M to 13.3 M (-0.03 %)
May 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.94	4,250	12,495	13,268,270	13.3 M to 13.3 M (-0.03 %)
May 14 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.85	2,500	7,125	7,468,878	7.5 M to 7.5 M (-0.03 %)
May 14 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.00	2,500	7,500	7,471,378	7.5 M to 7.5 M (-0.03 %)
May 14 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.89	2,500	7,237	7,473,878	7.5 M to 7.5 M (-0.03 %)
May 08 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.88	4,250	12,240	13,281,020	13.3 M to 13.3 M (-0.03 %)
May 08 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.90	4,250	12,325	13,285,270	13.3 M to 13.3 M (-0.03 %)
May 08 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.00	4,250	12,750	13,289,520	13.3 M to 13.3 M (-0.03 %)
May 08 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Gift	G	0.00	78,540	0	13,293,770	13.4 M to 13.3 M (-0.59 %)
May 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.90	4,250	12,325	13,272,520	13.3 M to 13.3 M (-0.03 %)
May 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.94	4,250	12,495	13,276,770	13.3 M to 13.3 M (-0.03 %)
May 09 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.94	2,500	7,338	7,476,378	7.5 M to 7.5 M (-0.03 %)
May 09 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.86	2,500	7,145	7,478,878	7.5 M to 7.5 M (-0.03 %)
May 09 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.94	2,500	7,338	7,481,378	7.5 M to 7.5 M (-0.03 %)
May 06 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.00	2,500	7,510	7,483,878	7.5 M to 7.5 M (-0.03 %)
May 06 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.02	2,500	7,551	7,486,378	7.5 M to 7.5 M (-0.03 %)
May 06 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.05	2,500	7,625	7,488,878	7.5 M to 7.5 M (-0.03 %)
May 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.01	4,250	12,793	13,372,310	13.4 M to 13.4 M (-0.03 %)
May 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.06	4,250	13,005	13,376,560	13.4 M to 13.4 M (-0.03 %)
May 01 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.17	2,500	7,920	7,491,378	7.5 M to 7.5 M (-0.03 %)
May 01 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	3.19	2,500	7,985	7,493,878	7.5 M to 7.5 M (-0.03 %)
May 01 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.99	2,500	7,485	7,496,378	7.5 M to 7.5 M (-0.03 %)
May 01 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.09	4,250	13,133	13,380,810	13.4 M to 13.4 M (-0.03 %)
May 01 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.19	4,250	13,558	13,385,060	13.4 M to 13.4 M (-0.03 %)
May 01 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.99	4,250	12,708	13,389,310	13.4 M to 13.4 M (-0.03 %)
Apr 26 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.85	2,500	7,127	7,498,878	7.5 M to 7.5 M (-0.03 %)
Apr 26 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.94	2,500	7,360	7,501,378	7.5 M to 7.5 M (-0.03 %)
Apr 26 2013	NVIV	INVIVO THERAPEUTIC ...	LANGER ROBERT	10% Owner	Sell	S	2.96	2,500	7,405	7,503,878	7.5 M to 7.5 M (-0.03 %)
Apr 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.84	4,250	12,070	13,393,560	13.4 M to 13.4 M (-0.03 %)
Apr 26 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.88	4,250	12,240	13,397,810	13.4 M to 13.4 M (-0.03 %)
Apr 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.95	4,250	12,538	13,402,060	13.4 M to 13.4 M (-0.03 %)
Apr 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.98	4,250	12,665	13,406,310	13.4 M to 13.4 M (-0.03 %)
Apr 24 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.12	4,250	13,260	13,410,560	13.4 M to 13.4 M (-0.03 %)
Apr 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.14	4,250	13,345	13,414,810	13.4 M to 13.4 M (-0.03 %)
Apr 19 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.15	4,250	13,388	13,419,060	13.4 M to 13.4 M (-0.03 %)
Apr 18 2013	NVIV	INVIVO THERAPEUTIC ...	MCCARTHY JOHN A JR	Director	Option Exercise	A	3.24	50,000	162,000	50,000
Apr 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.27	4,250	13,898	13,423,310	13.4 M to 13.4 M (-0.03 %)
Apr 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.18	4,250	13,515	13,427,560	13.4 M to 13.4 M (-0.03 %)
Apr 17 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.27	4,250	13,898	13,431,810	13.4 M to 13.4 M (-0.03 %)
Apr 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.20	4,250	13,600	13,436,060	13.4 M to 13.4 M (-0.03 %)
Apr 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.12	4,250	13,260	13,440,310	13.4 M to 13.4 M (-0.03 %)
Apr 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.03	4,250	12,878	13,444,560	13.4 M to 13.4 M (-0.03 %)
Apr 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	3.12	4,250	13,260	13,448,810	13.5 M to 13.4 M (-0.03 %)
Apr 10 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.93	4,250	12,453	13,453,060	13.5 M to 13.5 M (-0.03 %)
Apr 05 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.82	4,250	11,985	13,457,310	13.5 M to 13.5 M (-0.03 %)
Apr 05 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.71	4,250	11,518	13,461,560	13.5 M to 13.5 M (-0.03 %)
Apr 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.28	4,250	9,690	13,465,810	13.5 M to 13.5 M (-0.03 %)
Apr 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.27	4,250	9,648	13,470,060	13.5 M to 13.5 M (-0.03 %)
Apr 03 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.27	4,250	9,648	13,474,310	13.5 M to 13.5 M (-0.03 %)
Mar 28 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.40	4,250	10,200	13,478,560	13.5 M to 13.5 M (-0.03 %)
Mar 27 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.46	4,250	10,455	13,482,810	13.5 M to 13.5 M (-0.03 %)
Mar 27 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.44	4,250	10,370	13,487,060	13.5 M to 13.5 M (-0.03 %)
Mar 27 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.44	4,250	10,370	13,491,310	13.5 M to 13.5 M (-0.03 %)
Mar 22 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.48	4,250	10,540	13,495,560	13.5 M to 13.5 M (-0.03 %)
Mar 22 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.44	4,250	10,370	13,499,810	13.5 M to 13.5 M (-0.03 %)
Mar 20 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.40	4,250	10,200	13,504,060	13.5 M to 13.5 M (-0.03 %)
Mar 20 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.38	4,250	10,115	13,508,310	13.5 M to 13.5 M (-0.03 %)
Mar 20 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.40	4,250	10,200	13,512,560	13.5 M to 13.5 M (-0.03 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.46	2,000	4,920	13,516,810	13.5 M to 13.5 M (-0.01 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.45	1,000	2,450	13,518,810	13.5 M to 13.5 M (-0.01 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.44	1,250	3,050	13,519,810	13.5 M to 13.5 M (-0.01 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.26	4,250	9,605	13,521,060	13.5 M to 13.5 M (-0.03 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.25	500	1,125	13,525,310	13.5 M to 13.5 M (0.00 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.22	2,500	5,550	13,525,810	13.5 M to 13.5 M (-0.02 %)
Mar 15 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.20	1,250	2,750	13,528,310	13.5 M to 13.5 M (-0.01 %)
Mar 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.22	1,200	2,664	13,529,560	13.5 M to 13.5 M (-0.01 %)
Mar 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.21	2,100	4,641	13,530,760	13.5 M to 13.5 M (-0.02 %)
Mar 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.20	950	2,090	13,532,860	13.5 M to 13.5 M (-0.01 %)
Mar 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.14	4,250	9,095	13,533,810	13.5 M to 13.5 M (-0.03 %)
Mar 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.26	300	678	13,538,060	13.5 M to 13.5 M (0.00 %)
Mar 12 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.15	3,950	8,493	13,538,360	13.5 M to 13.5 M (-0.03 %)
Mar 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.30	4,250	9,775	13,542,310	13.5 M to 13.5 M (-0.03 %)
Mar 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.25	1,000	2,250	13,546,560	13.5 M to 13.5 M (-0.01 %)
Mar 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.21	1,000	2,210	13,547,560	13.5 M to 13.5 M (-0.01 %)
Mar 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.20	2,250	4,950	13,548,560	13.6 M to 13.5 M (-0.02 %)
Mar 07 2013	NVIV	INVIVO THERAPEUTIC ...	REYNOLDS FRANCIS	CEO, CFO	Sell	S	2.34	1,000	2,340	13,550,810	13.6 M to 13.6 M (-0.01 %)

Page: < prev 1 2 3 4 5 next >